Related Experiment Video
Updated: Jun 24, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Treatment of mediastinal fibrosis with mycophenolate mofetil
Michael Witschi1, Mathias Gugger, Laurent P Nicod
1Clinic and Polyclinic of Pneumology, Bern University Hospital, Bern, Switzerland.
Abstract:
We present the case of a 67-year-old male patient with mediastinal and retroperitoneal fibrosis. In Europe, this is a rare disease. Treatment was established to prevent complications due to strictures or compressions. Because of his diabetes, a therapy of low-dose prednisone combined with mycophenolate mofetil, known as steroid sparing agent, was applied. As a result, the radiological follow-up showed a marked decrease in the mediastinal and retroperitoneal masses.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Mitral Stenosis III: Medical Management
Myocarditis III: Medical Management
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
